utilization management controls for antipsychotic prescription drugs under the Medical Assistance program

Healthcare

Did Not Pass

The latest official action shows that this bill did not move forward in that session.

Sponsor: Representatives Novak, Gundrum, B. Jacobson, Mursau, Sortwell, Steffen and Tittl, cosponsored by Senators James, Cabral-Guevara and Wanggaard
Last action: 2026-03-23
Official status: A - Health, Aging and Long-Term Care
Effective date: Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

2026-03-23 Asm.
Failed to pass pursuant to Senate Joint Resolution 1
2025-10-29 Asm.
Fiscal estimate received
2025-10-15 Asm.
Public hearing held
2025-09-09 Asm.
Representative Subeck added as a coauthor
2025-08-28 Asm.
Assembly Substitute Amendment 2 offered by Representative Novak
2025-05-15 Asm.
Assembly Substitute Amendment 1 offered by Representative Novak
2025-04-04 Asm.
Fiscal estimate received
2025-02-24 Asm.
Introduced by Representatives Novak , Gundrum , B. Jacobson , Mursau , Sortwell , Steffen and Tittl ; cosponsored by Senators James , Cabral-Guevara and Wanggaard
2025-02-24 Asm.
Read first time and referred to Committee on Health, Aging and Long-Term Care

Official Summary Text

utilization management controls for antipsychotic prescription drugs under the Medical Assistance program
Status: A - Health, Aging and Long-Term Care